These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 3010744)

  • 1. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.
    Rubanyi GM; Vanhoutte PM
    Am J Physiol; 1986 May; 250(5 Pt 2):H822-7. PubMed ID: 3010744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle.
    Rubanyi GM; Vanhoutte PM
    Am J Physiol; 1986 May; 250(5 Pt 2):H815-21. PubMed ID: 3085520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines.
    Rubanyi GM; Lorenz RR; Vanhoutte PM
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H95-101. PubMed ID: 3874557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy.
    Greenberg SS; Wilcox DE; Rubanyi GM
    Circ Res; 1990 Dec; 67(6):1446-52. PubMed ID: 2173981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is nitric oxide the only endothelium-derived relaxing factor in canine femoral veins?
    Miller VM; Vanhoutte PM
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1910-6. PubMed ID: 2513730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
    Rubanyi GM; McKinney M; Vanhoutte PM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism underlying the inhibitory interaction between the nitrovasodilator SIN-1 and the endothelium.
    Flavahan NA; Vanhoutte PM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S86-90. PubMed ID: 2484707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-induced release of endothelium-derived relaxing factor.
    Rubanyi GM; Romero JC; Vanhoutte PM
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1145-9. PubMed ID: 3487253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries.
    Rubanyi GM; Hoeffner U; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):60-4. PubMed ID: 2455796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity.
    Mügge A; Elwell JH; Peterson TE; Harrison DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C219-25. PubMed ID: 1847583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine arteries release two different endothelium-derived relaxing factors.
    Hoeffner U; Feletou M; Flavahan NA; Vanhoutte PM
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H330-3. PubMed ID: 2787604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium-free solution prevents the action but not the release of endothelium-derived relaxing factor.
    Rubanyi GM; Vanhoutte PM
    Eur J Pharmacol; 1988 Jan; 145(3):351-5. PubMed ID: 3258243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium-induced release of endothelium-derived relaxing factor from canine femoral arteries.
    Rubanyi GM; Vanhoutte PM
    Circ Res; 1988 Jun; 62(6):1098-103. PubMed ID: 3260148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of EDRF from canine renal artery by leukotriene D4.
    Pawloski JR; Chapnick BM
    Am J Physiol; 1990 May; 258(5 Pt 2):H1449-56. PubMed ID: 2159728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery.
    Guo HY; Loren RR; Vanhutte PM
    Chin Med J (Engl); 1992 Aug; 105(8):666-70. PubMed ID: 1458970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM; Vanhoutte PM
    Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
    Rubanyi GM; Desiderio D; Luisi A; Johns A; Sybertz EJ
    J Pharmacol Exp Ther; 1989 Jun; 249(3):858-63. PubMed ID: 2499677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated coronary relaxation after reperfusion: effects of superoxide dismutase and TxA2 inhibitor U 63557A.
    Mehta JL; Lawson DL; Nichols WW
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1240-6. PubMed ID: 2552841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig.
    Shimokawa H; Flavahan NA; Lorenz RR; Vanhoutte PM
    Br J Pharmacol; 1988 Dec; 95(4):1197-203. PubMed ID: 3064855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.